rs1554122896
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001999.4(FBN2):c.3719G>A(p.Cys1240Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1240R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN2 | NM_001999.4 | c.3719G>A | p.Cys1240Tyr | missense_variant | 28/65 | ENST00000262464.9 | NP_001990.2 | |
FBN2 | XM_017009228.3 | c.3566G>A | p.Cys1189Tyr | missense_variant | 27/64 | XP_016864717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN2 | ENST00000262464.9 | c.3719G>A | p.Cys1240Tyr | missense_variant | 28/65 | 1 | NM_001999.4 | ENSP00000262464 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2017 | The p.C1240Y variant (also known as c.3719G>A), located in coding exon 28 of the FBN2 gene, results from a G to A substitution at nucleotide position 3719. The cysteine at codon 1240 is replaced by tyrosine, an amino acid with highly dissimilar properties. In one study, 13 of 14 reported FBN2 mutations were found in the middle region of the gene (exons 24-36), and 7 of these mutations were noted to alter or produce a cysteine residue (Callewaert BL et al. Hum Mutat. 2009;30(3):334-341). Based on internal structural analysis, p.C1240Y is predicted to eliminate a conserved disulfide in the cb EGF-like domain #15, suggesting disruption of folding of this domain (Downing AK et al. Cell. 1996;85:597-605). In one study, this variant was reported in a child with Beals syndrome (also known as congenital contractural arachnodactyly (CCA)), and the authors described the occurrence to be de novo (Semyachkina AN et al. Russian Bulletin of Perinatology and Pediatrics. 2016;61(5):47-51 [In Russian]). Another alteration involving the same amino acid, p.C1240R (referred to as p.C1239R), also has been reported in a patient with CCA (Gupta PA et al. Hum Mutat. 2002;19:39-48). This amino acid position is highly conserved in available vertebrate species. In addition, p.C1240Y is predicted to be probably damaging and deleterious by PolyPhen and SIFT in silico analyses, respectively. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Congenital contractural arachnodactyly Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 10, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant affects a cysteine residue located within an epidermal growth factor (EGF)–like domain of the FBN2 protein. Cysteine residues in these domains are involved in the formation of disulfide bridges critical for protein structure and stability (PMID: 3495735, 4750422, 16677079). In addition, missense substitutions within the FBN2 EGF-like domains affecting cysteine residues are overrepresented in patients with congenital contractural arachnodactyly (PMID: 18767143). This variant has been observed in individual(s) with congenital contractural arachnodactyly (PMID: 31316167). ClinVar contains an entry for this variant (Variation ID: 519834). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 1240 of the FBN2 protein (p.Cys1240Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at